Flinton Capital Management LLC raised its stake in shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 30.3% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 23,940 shares of the software maker’s stock after purchasing an additional 5,572 shares during the period. Flinton Capital Management LLC’s holdings in Allscripts Healthcare Solutions were worth $348,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Avestar Capital LLC bought a new stake in Allscripts Healthcare Solutions during the fourth quarter valued at about $173,000. Sheaff Brock Investment Advisors LLC bought a new stake in Allscripts Healthcare Solutions during the third quarter valued at about $174,000. Quantitative Systematic Strategies LLC bought a new stake in Allscripts Healthcare Solutions during the fourth quarter valued at about $182,000. Crossmark Global Holdings Inc. bought a new stake in Allscripts Healthcare Solutions during the third quarter valued at about $187,000. Finally, Oakbrook Investments LLC bought a new position in shares of Allscripts Healthcare Solutions in the fourth quarter worth about $194,000.

How to Become a New Pot Stock Millionaire

Shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) opened at $12.44 on Friday. The company has a debt-to-equity ratio of 1.33, a current ratio of 0.97 and a quick ratio of 0.97. The company has a market capitalization of $2,340.21, a PE ratio of 27.53, a P/E/G ratio of 1.66 and a beta of 1.20. Allscripts Healthcare Solutions Inc has a 52-week low of $11.25 and a 52-week high of $16.13.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its earnings results on Thursday, February 15th. The software maker reported $0.18 EPS for the quarter, hitting analysts’ consensus estimates of $0.18. The company had revenue of $547.00 million for the quarter, compared to the consensus estimate of $524.05 million. Allscripts Healthcare Solutions had a positive return on equity of 7.36% and a negative net margin of 10.88%. The firm’s revenue for the quarter was up 27.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.14 earnings per share. analysts anticipate that Allscripts Healthcare Solutions Inc will post 0.56 EPS for the current fiscal year.

A number of equities analysts have recently weighed in on MDRX shares. BidaskClub raised Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research note on Wednesday, December 20th. Citigroup started coverage on Allscripts Healthcare Solutions in a research note on Thursday, January 4th. They issued a “buy” rating for the company. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $17.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Monday, January 8th. Maxim Group reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Allscripts Healthcare Solutions in a research note on Tuesday, January 9th. Finally, Royal Bank of Canada set a $19.00 price objective on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research note on Thursday, January 11th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have issued a buy rating to the company. Allscripts Healthcare Solutions presently has a consensus rating of “Buy” and an average price target of $16.09.

In related news, EVP Brian Farley sold 5,000 shares of the business’s stock in a transaction dated Wednesday, March 14th. The stock was sold at an average price of $13.73, for a total value of $68,650.00. Following the sale, the executive vice president now directly owns 240,672 shares in the company, valued at $3,304,426.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, President Richard J. Poulton sold 15,000 shares of the business’s stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $13.53, for a total value of $202,950.00. Following the completion of the sale, the president now owns 505,920 shares in the company, valued at $6,845,097.60. The disclosure for this sale can be found here. 0.75% of the stock is currently owned by insiders.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at https://www.watchlistnews.com/flinton-capital-management-llc-buys-5572-shares-of-allscripts-healthcare-solutions-inc-mdrx/1959511.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.